Elizabeth Maynard

1.1k total citations
9 papers, 966 citations indexed

About

Elizabeth Maynard is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Elizabeth Maynard has authored 9 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Elizabeth Maynard's work include Cancer Cells and Metastasis (3 papers), Angiogenesis and VEGF in Cancer (2 papers) and Cell Adhesion Molecules Research (2 papers). Elizabeth Maynard is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Angiogenesis and VEGF in Cancer (2 papers) and Cell Adhesion Molecules Research (2 papers). Elizabeth Maynard collaborates with scholars based in United States and Japan. Elizabeth Maynard's co-authors include Peter Oettgen, Arthur M. Mercurio, David I. Bellovin, Bingyan Wu, Courtney Brown, Richard C. Bates, Hisaaki Kawakatsu, Dean Sheppard, H. S. Thompson and Stylianos P. Scordilis and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Elizabeth Maynard

9 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Maynard United States 8 503 331 316 193 138 9 966
Marina Strasly Italy 8 488 1.0× 337 1.0× 207 0.7× 129 0.7× 203 1.5× 10 907
Carl-Henrik Heldin Sweden 7 478 1.0× 107 0.3× 181 0.6× 155 0.8× 94 0.7× 8 822
Christiane Arnold France 15 363 0.7× 309 0.9× 228 0.7× 195 1.0× 115 0.8× 20 919
F. Gumkowski United States 9 349 0.7× 247 0.7× 128 0.4× 295 1.5× 78 0.6× 9 728
Jean Delbé France 21 762 1.5× 239 0.7× 143 0.5× 435 2.3× 96 0.7× 46 1.3k
Benoît Langlois France 15 358 0.7× 250 0.8× 179 0.6× 226 1.2× 130 0.9× 19 857
Bernd Algermissen Germany 14 262 0.5× 163 0.5× 240 0.8× 93 0.5× 457 3.3× 26 956
J Bradley Australia 12 405 0.8× 150 0.5× 309 1.0× 79 0.4× 225 1.6× 18 885
Sunish Mohanan United States 14 490 1.0× 152 0.5× 481 1.5× 196 1.0× 305 2.2× 24 1.3k
Mumtaz V. Rojiani United States 14 537 1.1× 182 0.5× 169 0.5× 161 0.8× 121 0.9× 29 931

Countries citing papers authored by Elizabeth Maynard

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Maynard more than expected).

Fields of papers citing papers by Elizabeth Maynard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Maynard. The network helps show where Elizabeth Maynard may publish in the future.

Co-authorship network of co-authors of Elizabeth Maynard

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Maynard. A scholar is included among the top collaborators of Elizabeth Maynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Maynard. Elizabeth Maynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Maynard, Elizabeth, Matthew McKinney, Linda Sutton, et al.. (2024). Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United States. Current Oncology. 31(11). 7244–7257. 1 indexed citations
2.
Okada, Yoshiaki, Kiichiro Yano, Enjing Jin, et al.. (2007). A Three-Kilobase Fragment of the Human Robo4 Promoter Directs Cell Type–Specific Expression in Endothelium. Circulation Research. 100(12). 1712–1722. 58 indexed citations
3.
Ni, Weihua, Yumei Zhan, Huamei He, et al.. (2007). Ets-1 Is a Critical Transcriptional Regulator of Reactive Oxygen Species and p47 phox Gene Expression in Response to Angiotensin II. Circulation Research. 101(10). 985–994. 75 indexed citations
4.
Bellovin, David I., Kaylene J. Simpson, Elizabeth Maynard, et al.. (2006). Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene. 25(52). 6959–6967. 105 indexed citations
5.
Bates, Richard C., David I. Bellovin, Courtney Brown, et al.. (2005). Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. Journal of Clinical Investigation. 115(2). 339–347. 291 indexed citations
6.
Bates, Richard C., David I. Bellovin, Courtney Brown, et al.. (2005). Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. Journal of Clinical Investigation. 115(2). 339–347. 267 indexed citations
7.
Ni, Weihua, et al.. (2005). Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. Blood. 107(8). 3153–3160. 43 indexed citations
8.
Thompson, H. S., et al.. (2003). Exercise‐induced HSP27, HSP70 and MAPK responses in human skeletal muscle. Acta Physiologica Scandinavica. 178(1). 61–72. 109 indexed citations
9.
Pennell, Christopher A., Elizabeth Maynard, L W Arnold, Geoffrey Haughton, & Sandra Clarke. (1990). High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice.. The Journal of Immunology. 145(5). 1592–1597. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026